Abstract:Objectives In the study, we hypothesised menstrual blood stem cells (MBSCs) protect ischaemic myocardium through paracrine effect. Methods MBSCs were isolated and expanded from human female menstrual blood. Then we infused the MBSCs intramyocardially in a rat acute myocardial infarction model, and cocultured MBSCs with neonatal rat cardiomyocytes (NRCs). Results In vitro experiments, the apoptosis ratio of NRCs underwent hypoxia/reoxygenation in coculture group was lower than the control group (8.95±1.32% vs 18.42±1.80%, p<0.01), and intracellular ROS generation was also lower (change fold, 27.8±4.1% vs 80.0±12.7%, p<0.01). The medium of normoxia and hypoxia cultured MBSCs was determined the secreted EGF, VEGF and TGF-β (559±21, 0, 635±59 ng/ml in normoxia culture respectively, 582±19, 198±6, 664±102 ng/ml in hypoxia culture respectively). The RNA was also extracted and reverse transcriptional PCR showed that MBSCs expressed multiple cytokines. The MBSCs were transplanted intramyocardially after ligation of the left anterior descending (LAD) in rats. After 48 h, less apoptotic cardiomyocytes were detected in the transplant group (infarct, 54.24±2.10% vs 67.97±3.28%, p<0.01; peri-infarct, 6.93±1.05% vs 11.88±1.47%, p<0.05) and western blot showed higher level of AKT phosphorylation and upregulation of BAX, as well as the decreased expression of cleaved caspase 9. 4 weeks later, 18-fluorodeoxyglucose microPET images indicated more viable cardiomyocytes in the scar area of transplant group than those of saline group (0.357±0.067 vs 0.275±0.053, p<0.01 in transverse section, 0.333±0.046 vs 0.267±0.045, p<0.01 in coronal section). The infarct size of transplant group was less than saline group in Masson9s trichrome stain (33.6±2.9% vs 41.6±4.9%, p<0.05). Immunofluorescence of the peri-infarct and infarct region by vWF and α-SMA staining showed obviously higher vessel density in the transplant group (vWF positive microvessels, 186±16/field vs 118±12/field, p<0.05; α-SMA positive arteriole, 35±7/field vs 21±6/field, p<0.05). Few differentiation of MBSCs toward endotheliocyte, smooth muscle cell and cardiomyocytes were found and no specific immune cell infiltration were observed around the MBSCs in vivo. Conclusions MBSCs paracrined multiple cytokines to protect cardiomyocytes from apoptosis and stimulate angiogenesis, which rescued the myocardium in the infarct region and finally resulted in a better cardiac function.

Rosuvastatin enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells for myocardial infarction via PI3K/Akt and MEK/ERK pathways

Rosuvastatin Treatment Activates JAK-STAT Pathway and Increases Efficacy of Allogeneic Mesenchymal Stem Cell Transplantation in Infarcted Hearts.

Rosuvastatin Prevents Adipose-derived Mesenchymal Stem Cells from Hypoxia/Reoxygenation Injury through Activation of ERK and AKT

Lovastatin Protects Mesenchymal Stem Cells Against Hypoxia- And Serum Deprivation-Induced Apoptosis By Activation Of Pi3k/Akt And Erk1/2

SRT1720 Pretreatment Promotes Mitochondrial Biogenesis of Aged Human Mesenchymal Stem Cells and Improves Their Engraftment in Postinfarct Nonhuman Primate Hearts.

Effects of Mesenchymal Stem Cells Transplantation on Post-Infarction Ventricular Remodeling in Rats

Menstrual Blood Stem Cells Rescue Myocardiocytes in Rat Myocardial Infarction by Regulating Redox and Decreasing ROS Generation Through Paracrine Action

MENSTRUAL BLOOD STEM CELLS IMPROVED MYOCARDIAL SURVIVAL AFTER RAT MYOCARDIAL INFARCTION BY PARACRINE

Rosuvastatin Enhances Lymphangiogenesis after Myocardial Infarction by Regulating the miRNAs/Vascular Endothelial Growth Factor Receptor 3 (miRNAs/VEGFR3) Pathway

Mesenchymal Stem Cells Preconditioned with High Density Lipoprotein Resist Oxidative Stress-Induced Apoptosis and Improve Cardiac Function in A Rat Model of Myocardial Infarction

Atorvastatin Treatment Improves Survival and Effects of Implanted Mesenchymal Stem Cells in Post-Infarct Swine Hearts

Atorvastatin Treatment of Rats with Ischemia-Reperfusion Injury Improves Adipose-Derived Mesenchymal Stem Cell Migration and Survival Via the SDF-1α/CXCR-4 Axis.

Ghrelin Improves Functional Survival of Engrafted Adipose-Derived Mesenchymal Stem Cells in Ischemic Heart Through PI3K/Akt Signaling Pathway.

Activation of liver X receptor improves viability of adipose-derived mesenchymal stem cells to attenuate myocardial ischemia injury through TLR4/NF-κB and Keap-1/Nrf-2 signaling pathways.

SRT1720 Promotes Survival of Aged Human Mesenchymal Stem Cells Via FAIM: a Pharmacological Strategy to Improve Stem Cell-Based Therapy for Rat Myocardial Infarction

Atorvastatin Enhance Efficacy Of Mesenchymal Stem Cells Treatment For Swine Myocardial Infarction Via Activation Of Nitric Oxide Synthase

High Density Lipoprotein Protects Mesenchymal Stem Cells from Oxidative Stress-Induced Apoptosis Via Activation of the PI3K/Akt Pathway and Suppression of Reactive Oxygen Species

Direct administration of mesenchymal stem cell-derived mitochondria improves cardiac function after infarction via ameliorating endothelial senescence

Mesenchymal stem cells with overexpression of midkine enhance cell survival and attenuate cardiac dysfunction in a rat model of myocardial infarction

Therapeutic Potential of Angiogenin Modified Mesenchymal Stem Cells: Angiogenin Improves Mesenchymal Stem Cells Survival under Hypoxia and Enhances Vasculogenesis in Myocardial Infarction.

Transplantation with Survivin‐engineered Mesenchymal Stem Cells Results in Better Prognosis in a Rat Model of Myocardial Infarction